Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice.
暂无分享,去创建一个
G. L. Kedderis | R R Maronpot | R. Maronpot | T. Goldsworthy | G L Kedderis | T L Goldsworthy | R Fransson-Steen | R. Fransson-Steen | Thomas L. Goldsworthy | Robert R. Maronpot | Ronny Fransson-Steen
[1] G. L. Kedderis,et al. Furan-mediated uncoupling of hepatic oxidative phosphorylation in Fischer-344 rats: an early event in cell death. , 1997, Toxicology and applied pharmacology.
[2] R. Conolly,et al. Apoptosis and cancer risk assessment. , 1996, Mutation research.
[3] A. Cossarizza,et al. Control of apoptosis by the cellular ATP level , 1996, FEBS letters.
[4] R. Maronpot,et al. Importance of and Approaches to Quantification of Hepatocyte Apoptosis , 1996, Toxicologic pathology.
[5] L A Peterson,et al. Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. , 1995, Chemical research in toxicology.
[6] H. Steller. Mechanisms and genes of cellular suicide , 1995, Science.
[7] R. Jirtle,et al. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. , 1995, Cancer research.
[8] B. Ruttkay-Nedecky,et al. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] W. Garland,et al. A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[10] G. L. Kedderis,et al. Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry. , 1993, Toxicology and applied pharmacology.
[11] R. Maronpot,et al. Concepts, labeling procedures, and design of cell proliferation studies relating to carcinogenesis. , 1993, Environmental health perspectives.
[12] M L Gargas,et al. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. , 1993, Toxicology and applied pharmacology.
[13] W. Bursch,et al. Cell proliferation and apoptosis in normal liver and preneoplastic foci. , 1993, Environmental health perspectives.
[14] W. Bursch,et al. Apoptosis is induced by transforming growth factor‐β1 within 5 hours in regressing liver without significant fragmentation of the DNA , 1993, Hepatology.
[15] E. Jeffery,et al. Separation of the toxic and glutathione-enhancing effects of the naturally occurring nitrile, cyanohydroxybutene. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[16] E G Luebeck,et al. Interpretation of labeling indices in the presence of cell death. , 1992, Carcinogenesis.
[17] G. M. Ledda-Columbano,et al. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. , 1991, The American journal of pathology.
[18] R. Irwin,et al. Disposition of [14C]furan in the male F344 rat. , 1991, Journal of toxicology and environmental health.
[19] W. Bursch,et al. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. , 1990, Carcinogenesis.
[20] W. H. Butler,et al. Apoptosis—the mechanism of cell death in dimethylnitrosamine‐induced hepatotoxicity , 1989, The Journal of pathology.
[21] M. Ripple,et al. In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology. , 1988, Biochemical pharmacology.
[22] H. Pitot,et al. The stages of initiation and promotion in hepatocarcinogenesis. , 1980, Biochimica et biophysica acta.
[23] R. O’brien,et al. A General ANOVA Method for Robust Tests of Additive Models for Variances , 1979 .
[24] J. Mitchell,et al. Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. , 1977, Toxicology and applied pharmacology.
[25] E. Cooper,et al. THE BIOLOGY OF CELL DEATH IN TUMOURS , 1973, Cell and tissue kinetics.
[26] Williams Da,et al. The comparison of several dose levels with a zero dose control. , 1972 .
[27] H. Greenberg. Progress in Liver Disease , 1970 .
[28] S. Shapiro,et al. An Analysis of Variance Test for Normality (Complete Samples) , 1965 .
[29] O. J. Dunn. Multiple Comparisons Using Rank Sums , 1964 .
[30] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[31] W. Kruskal,et al. Use of Ranks in One-Criterion Variance Analysis , 1952 .
[32] W. Bursch,et al. 7 – Apoptosis and hepatocarcinogenesis , 1995 .
[33] W. Bursch,et al. Active cell death (apoptosis) in liver biology and disease. , 1995, Progress in liver diseases.
[34] W. W. Nichols,et al. Rapid DNA degradation in primary rat hepatocytes treated with diverse cytotoxic chemicals: Analysis by pulsed field gel electrophoresis and implications for alkaline elution assays , 1994, Environmental and molecular mutagenesis.
[35] B E Butterworth,et al. Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan , 1992, Environmental and molecular mutagenesis.
[36] R. Morais,et al. Degenerative changes, DNA synthesis and mitotic activity in rat liver following single exposure to diethylnitrosamine. , 1986, Chemico-biological interactions.
[37] E. Zeiger,et al. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.
[38] A. Yamaguchi,et al. The effects of diethyldithiocarbamate and carbon disulfide on acute nephrotoxicity induced by furan, bromobenzene and cephaloridine in mice. , 1984, Japanese journal of pharmacology.